Tumor Development, Growth Characteristics and Spectrum of Genetic Aberrations in the TH-MYCN Mouse Model of Neuroblastoma

Chemotherapy-Induced Apoptosis in a Transgenic Model of Neuroblastoma Proceeds Through p53 Induction

(2015) Louis Chesler et al.   NEOPLASIA

Preclinical Models for Neuroblastoma: Establishing a Baseline for Treatment

(2011) Tal Teitz et al.   PLoS One

Genetically engineered murine models – Contribution to our understanding of the genetics, molecular pathology and therapeutic targeting of neuroblastoma

(2011) Louis Chesler et al.   SEMINARS IN CANCER BIOLOGY

Serial Transcriptome Analysis and Cross-Species Integration IdentifiesCentromere-Associated Protein Eas a Novel Neuroblastoma Target

(2010) Naomi J. Balamuth et al.   CANCER RESEARCH

High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset

(2010) H. Caren et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Embryonal neural tumours and cell death

(2009) John Inge Johnsen et al.   APOPTOSIS

A Simple PCR Method for Rapid Genotype Analysis of the TH-MYCN Transgenic Mouse

(2009) Seiki Haraguchi et al.   PLoS One

High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors; Four cases of homozygous deletions of the CDKN2A gene

(2008) Helena Caren et al.   BMC GENOMICS

ODC1 Is a Critical Determinant of MYCN Oncogenesis and a Therapeutic Target in Neuroblastoma

(2008) M. D. Hogarty et al.   CANCER RESEARCH